| 711348 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Ocular adverse events in PD-1 and PD-L1 inhibitors |
2021-07-01 |
10.1136/jitc-2020-002119 |
Young LeAnne, Finnigan Shanda, Streicher Howard, Chen Helen X, Murray James, Sen H Nida, Sharon Elad |
| 711347 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Escherichia coli adhesin protein-conjugated thermal responsive hybrid nanoparticles for photothermal and immunotherapy against cancer and its metastasis |
2021-07-01 |
10.1136/jitc-2021-002666 |
Hwang Juyoung, Zhang Wei, Park Hae-Bin, Yadav Dhananjay, Jeon Yong Hyun, Jin Jun-O |
| 711346 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects |
2021-07-01 |
10.1136/jitc-2021-002773 |
Veeramachaneni Ratna, Yu Wangjie, Newton Jared M, Kemnade Jan O, Skinner Heath D, Sikora Andrew G, Sandulache Vlad C |
| 711345 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Exercise and the immune system: taking steps to improve responses to cancer immunotherapy |
2021-07-01 |
10.1136/jitc-2020-001872 |
Gustafson Michael P, Wheatley-Guy Courtney M, Rosenthal Allison C, Gastineau Dennis A, Katsanis Emmanuel, Johnson Bruce D, Simpson Richard J |
| 711344 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis |
2021-07-01 |
10.1136/jitc-2021-002732 |
Bjursten Sara, Pandita Ankur, Zhao Zhiyuan, Fröjd Charlotta, Ny Lars, Jensen Christer, Ullerstam Tobias, Jespersen Henrik, Borén Jan, Levin Malin, Zetterberg Henrik, Rudin Anna, Levin Max |
| 711343 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Evaluating T-cell cross-reactivity between tumors and immune-related adverse events with TCR sequencing: pitfalls in interpretations of functional relevance |
2021-07-01 |
10.1136/jitc-2021-002642 |
Cottrell Tricia, Zhang Jiajia, Zhang Boyang, Kaunitz Genevieve J, Burman Poromendro, Chan Hok-Yee, Verde Franco, Hooper Jody E, Hammers Hans, Allaf Mohamad E, Ji Hongkai, Taube Janis, Smith Kellie N |
| 711342 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Co-delivery of novel bispecific and trispecific engagers by an amplicon vector augments the therapeutic effect of an HSV-based oncolytic virotherapy |
2021-07-01 |
10.1136/jitc-2021-002454 |
Ravirala Divya, Mistretta Brandon, Gunaratne Preethi H, Pei Guangsheng, Zhao Zhongming, Zhang Xiaoliu |
| 711341 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors |
2021-07-01 |
10.1136/jitc-2021-003019 |
Vonderheide Robert H, Kraynyak Kimberly A, Shields Anthony F, McRee Autumn J, Johnson Jennifer M, Sun Weijing, Chintakuntlawar Ashish V, Pawlicki Jan, Sylvester Albert J, McMullan Trevor, Samuels Robert, Kim Joseph J, Weiner David, Boyer Jean D, Morrow Matthew P, Humeau Laurent, Skolnik Jeffrey M |
| 711340 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer |
2021-07-01 |
10.1136/jitc-2021-002844 |
Stein Alexander, Simnica Donjete, Schultheiß Christoph, Scholz Rebekka, Tintelnot Joseph, Gökkurt Eray, von Wenserski Lisa, Willscher Edith, Paschold Lisa, Sauer Markus, Lorenzen Sylvie, Riera-Knorrenschild Jorge, Depenbusch Reinhard, Ettrich Thomas J, Dörfel Steffen, Al-Batran Salah-Eddin, Karthaus Meinolf, Pelzer Uwe, Waberer Lisa, Hinke Axel, Bauer Marcus, Massa Chiara, Seliger Barbara, Wickenhauser Claudia, Bokemeyer Carsten, Hegewisch-Becker Susanna, Binder Mascha |
| 711339 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies |
2021-07-01 |
10.1136/jitc-2021-002410 |
Çınar Özcan, Brzezicha Bernadette, Grunert Corinna, Kloetzel Peter Michael, Beier Christin, Peuker Caroline Anna, Keller Ulrich, Pezzutto Antonio, Busse Antonia |
